Medicines in Development for Immuno-Oncology 2017 Report
America’s biopharmaceutical research companies are developing more than 240 immuno-oncology treatments.
Interested in reading more on Medicines in Development for Immuno-Oncology 2017 Report?
Get your free copy of the report now.
OF CANCER DIAGNOSES
in the U.S. are people age 50 and older
OF U.S. POPULATION
are cancer survivors
U.S. CANCER DEATHS
were estimated in 2017
NEW CASES OF CANCER
estimated in 2017